Introduction
============

Nearly 11% of all births worldwide occur preterm (gestational age \<37 weeks).[@ref1] Preterm birth has been associated with long term health risks, not only in the offspring but also in mothers. Women who deliver preterm have been reported to have increased future risks of developing cardiometabolic disorders, even after controlling for other risk factors.[@ref2] [@ref3] [@ref4] Little is known about the long term mortality risks and underlying causes of death in these women, however. A better understanding of these outcomes is needed to identify women at high risk and guide their long term clinical care.

Previous studies have suggested that women who deliver an infant with low birth weight have higher subsequent all cause,[@ref5] [@ref6] [@ref7] cardiovascular,[@ref7] [@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] and diabetes related[@ref14] mortality, after controlling for other maternal factors. But the birth weight of infants reflects the length of the pregnancy and the fetal growth rate, which are determined by different underlying processes. Mortality risks associated specifically with preterm delivery have rarely been explored and the results are conflicting,[@ref8] [@ref9] [@ref10] possibly because of insufficient sample sizes and follow-up time. A Swedish study of 573 437 women reported that preterm delivery in 1973-80 was associated with a 23% (95% confidence interval 14% to 34%) increased mortality up to 1997, but did not examine narrower pregnancy lengths or potential confounding by other maternal factors.[@ref10] Furthermore, if such associations exist, whether they are a result of shared familial (genetic and environmental) factors that contribute to preterm delivery and early mortality, or more directly related to preterm delivery, is unclear.

To look at these knowledge gaps, we conducted a national cohort study of more than two million women in Sweden. Our goals were: to determine mortality risks associated with preterm delivery in a large population based cohort of women; to examine changes in these risks over time, with up to 44 years of follow-up; and to explore the potential influence of shared genetic or environmental factors within families by co-sibling analyses. We hypothesised that preterm delivery is associated with increased long term mortality and that this association might be independent of shared familial factors.

Methods
=======

Study population
----------------

The Swedish Medical Birth Register has prenatal and birth information for nearly all deliveries in Sweden since 1973, collected by the National Board of Health and Welfare.[@ref15] From this register, we identified 2 194 939 women who had a singleton delivery in 1973-2015. Singleton deliveries were selected to improve internal comparability, given the higher prevalence of preterm delivery and its different underlying causes in multiple gestation pregnancies.[@ref16] We excluded 5462 (0.2%) women who had missing information for length of pregnancy, leaving 2 189 477 women (99.8% of the original cohort) for inclusion in the study. The study was approved by the Regional Ethical Review Board, Lund, Sweden (No 2013/736). Participant consent was not required because the study used de-identified registry based secondary data.

Assessing length of pregnancy
-----------------------------

The length of the pregnancy was identified from the Swedish Medical Birth Register based on the maternal report of the last menstrual period in the 1970s and by ultrasonography starting in the 1980s and onwards (\>70% of the cohort). Length of pregnancy was examined alternatively as a continuous variable or categorical variable with six groups: extremely preterm (22-27 weeks), very preterm (28-33 weeks), late preterm (34-36 weeks), early term (37-38 weeks), full term (39-41 weeks, used as the reference group), and post-term (≥42 weeks). Also, the first three groups were combined to provide summary estimates for preterm delivery (\<37 weeks).

Determining mortality
---------------------

The study cohort was followed up for mortality from first delivery to 31 December 2016 (maximum follow-up time was 44 years; median 23.4 years). Mortality was identified from the Swedish Death Register, which includes all deaths and causes of death for all people registered in Sweden since 1960, with compulsory reporting nationwide. Cause specific mortality was examined for categories that had sufficient numbers for detailed analysis (\>500 total deaths), which included cardiovascular disease (international classification of diseases, eighth and ninth revisions (ICD-8/9) codes 393-459, international classification of diseases, 10th revision (ICD-10) codes I00-I99), any cancer (ICD-8/9 codes 140-209, ICD-10 codes C00-C99), breast cancer (ICD-8/9 code 174, ICD-10 code C50), respiratory disorders (ICD-8/9 codes 460-519, ICD-10 codes J00-J99), and diabetes mellitus (ICD-8/9 code 250, ICD-10 codes E10-E14).

Other study variables
---------------------

Maternal characteristics that might be associated with preterm delivery and mortality were identified by the Swedish Medical Birth Register and national census data, which were linked by an anonymous personal identification number and updated for each pregnancy. Maternal age was adjusted for in all analyses as the Cox model time scale (described below). Covariates included calendar year of delivery (continuous variable and categorical variable by decade), parity (1, 2, 3, 4, ≥5), highest educational level attained (≤9, 10-12, \>12 years), employment status (yes or no), and income (four equal groups) in the year before delivery, country or region of birth (Sweden; other Europe, United States, and Canada; Asia and Oceania; Africa; Latin America; other/unknown), body mass index (continuous and categorical \<18.5, 18.5-24.9, 25.0-26.9, 27.0-29.9, ≥30.0), and smoking (0, 1-9, ≥10 cigarettes/day) at the beginning of prenatal care, and pre-eclampsia (ICD-8 code 637; ICD-9 codes 624.4-624.7; ICD-10 codes O14-O15), other hypertensive disorders (ICD-8 codes 400-404; ICD-9 codes 401-405, 642.0-642.3, and 642.9; ICD-10 codes I10-I15, O10-O11, O13, and O15-O16), diabetes mellitus (that is, pregestational type 1 or type 2, or gestational diabetes, ICD-8 code 250; ICD-9 codes 250, 648.0, and 648.8; ICD-10 codes E10-E14 and O24), asthma (ICD-8/9 code 493; ICD-10 codes J45-J46), rheumatoid arthritis (ICD-8 code 712; ICD-9 code 714; ICD-10 codes M05-M06), and depression (ICD-8 code 300.4; ICD-9 code 311; ICD-10 codes F30-F39) before delivery.

Maternal body mass index and smoking were assessed at the beginning of prenatal care starting in 1982, and were available for 56.2% and 67.3% of women, respectively. Data were more than 99% complete for all other variables. Missing data for maternal body mass index or smoking were multiply imputed with linear regression and ordinal logistic regression, respectively, to produce 20 imputations, with all other covariates and mortality as predictors.[@ref17] [@ref18] As alternatives to multiple imputation, sensitivity analyses were performed that were restricted to women with complete data (n=1 201 932; 54.9%) or coded missing data for each variable with a missing data indicator.

Statistical analysis
--------------------

Cox proportional hazards regression was used to calculate hazard ratios and 95% confidence intervals for associations between length of pregnancy and subsequent all cause or cause specific mortality. These associations were examined across the maximum possible follow-up time (up to 44 years) and in narrower time intervals of follow-up (\<10, 10-19, and 20-44 years) in women who were still alive and living in Sweden at the beginning of the respective interval. Length of pregnancy was modelled as a time dependent variable with the exposure category determined by the shortest pregnancy so far. For example, if a woman's first delivery was full term and her second was preterm, she entered the preterm exposure category at the date of her second delivery. Attained age was used as the Cox model time axis, with age at delivery as time zero. Women were censored at emigration, determined by the absence of a Swedish residential address in the census data (n=93 098; 4.3%). Emigrants and non-emigrants had similar pregnancy lengths (median 40 weeks and one day for both groups), making it unlikely that emigration introduced substantial bias. Analyses were conducted unadjusted and adjusted for covariates (that is, a confounder adjusted analysis). The proportional hazards assumption was assessed by examining log-log plots,[@ref19] and no substantial departures were found. Also, a sensitivity analysis was performed that was restricted to each woman's first delivery instead of time dependent modelling of her shortest pregnancy.

Discordant co-sibling analyses were performed to assess for potential confounding effects of unmeasured shared familial (genetic and early life environmental) factors in all 1 188 730 (54.3%) women with at least one sister who had a singleton delivery.[@ref20] Shared environmental factors in families might include lifestyle factors, such as diet and physical activity, or ambient exposures, such as passive smoking or air pollution. These analyses used stratified Cox regression with a separate group for each set of sisters identified by their mother's anonymous identification number. In the stratified Cox model, each set of sisters had its own baseline hazard function that reflected their shared genetic and environmental factors, and thus associations between length of pregnancy and mortality were examined within the family, controlling for their shared factors. Also, these analyses were further adjusted for the same covariates as in the primary analyses.

Several other secondary analyses were performed. Firstly, associations between the number of preterm deliveries (0, 1, ≥2) and subsequent mortality were examined in women with at least two singleton deliveries (n=1 458 070). Secondly, mortality risks were assessed after stratifying by spontaneous (68.5%) or medically indicated (31.5%) preterm delivery, which was systematically recorded starting in 1990 (n=1 218 954; maximum 27 years of follow-up). Thirdly, interactions were explored between length of pregnancy and pre-eclampsia or fetal growth restriction (major causes of medically indicated preterm delivery) in relation to mortality on additive and multiplicative scales.[@ref21] In these analyses, pre-eclampsia was identified with the same ICD codes noted above, and fetal growth restriction was assessed as small for gestational age (birth weight \<10th centile for gestational age) compared with appropriate for gestational age (10th-90th centiles). Fourthly, we performed subanalyses that were stratified by maternal age (\<35 *v* ≥35) or calendar year (\<1980 *v* ≥1980) at first delivery. All statistical tests were two sided and used an α level of 0.05. All analyses were conducted with Stata version 15.1.

Patient and public involvement
------------------------------

No patients were involved in setting the research question or outcome measures, nor were they involved in other areas of the study design or implementation because of data protection restrictions and the technical methods required to perform a data linkage analysis. The results will be disseminated to patients and the public through a website and press releases suitable for a non-specialised audience.

Results
=======

[Table 1](#tbl1){ref-type="table"} reports maternal characteristics by length of pregnancy. Women who delivered preterm were more likely than those who delivered full term to be younger, have fewer years of education, be unemployed, have a high body mass index, smoke 10 or more cigarettes a day, or have pre-eclampsia, other hypertensive disorders, diabetes, asthma, rheumatoid arthritis, and depression.

###### 

Characteristics of study participants by shortest length of pregnancy, Sweden, 1973-2015. Data are number (%)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                  Extremely preterm (22-27 weeks; n=9107)   Very preterm\             Late preterm\    Early term\      Full term\         Post-term\
                                                                            (28-33 weeks; n=45 453)   (34-36 weeks;\   (37-38 weeks;\   (39-41 weeks;\     (≥42 weeks;\
                                                                                                      n=140 262)       n=551 854)       n=1 353 288)       n=89 513)
  ------------------------------- ----------------------------------------- ------------------------- ---------------- ---------------- ------------------ ---------------
  Age at first delivery (years)                                                                                                                            

   \<20                           806 (8.9)                                 4125 (9.1)                11 408 (8.1)     35 953 (6.5)     64 179 (4.7)       2810 (3.1)

   20-24                          2586 (28.4)                               13 335 (29.3)             42 393 (30.2)    162 343 (29.4)   364 050 (26.9)     17 756 (19.8)

   25-29                          2776 (30.5)                               14 590 (32.1)             47 287 (33.7)    194 633 (35.3)   498 643 (36.9)     31 062 (34.7)

   30-34                          1875 (20.6)                               9050 (19.9)               27 469 (19.6)    112 857 (20.4)   304 799 (22.5)     24 744 (27.6)

   35-39                          856 (9.4)                                 3502 (7.7)                9659 (6.9)       37 810 (6.9)     101 802 (7.5)      11 045 (12.3)

   ≥40                            208 (2.3)                                 851 (1.9)                 2046 (1.5)       8258 (1.5)       19 815 (1.5)       2096 (2.3)

  Year of delivery                                                                                                                                         

   1973-79                        1445 (15.9)                               10 135 (22.3)             31 075 (22.2)    112 458 (20.4)   338 112 (25.0)     33 917 (37.9)

   1980-89                        1773 (19.5)                               10 762 (23.7)             33 789 (24.1)    126 390 (22.9)   258 787 (19.1)     11 880 (13.3)

   1990-99                        1992 (21.9)                               10 008 (22.0)             30 445 (21.7)    121 720 (22.1)   267 628 (19.8)     12 207 (13.6)

   2000-09                        2244 (24.6)                               9334 (20.5)               29 165 (20.8)    126 519 (22.9)   279 267 (20.6)     12 950 (14.5)

   2010-15                        1653 (18.1)                               5214 (11.5)               15 788 (11.3)    64 767 (11.7)    209 494 (15.5)     18 559 (20.7)

  Final parity                                                                                                                                             

   1                              1726 (19.0)                               8351 (18.4)               23 570 (16.8)    86 312 (15.6)    326 645 (24.1)     46 393 (51.8)

   2                              3074 (33.7)                               18 081 (39.8)             62 541 (44.6)    263 495 (47.8)   669 721 (49.5)     29 682 (33.2)

   3                              2500 (27.5)                               11 462 (25.2)             34 768 (24.8)    140 378 (25.4)   269 132 (19.9)     9981 (11.2)

   4                              1128 (12.4)                               4746 (10.4)               12 665 (9.0)     42 744 (7.7)     64 302 (4.8)       2432 (2.7)

   ≥5                             678 (7.4)                                 2813 (6.2)                6718 (4.8)       18 925 (3.4)     23 488 (1.7)       1025 (1.1)

  Education (No of years)                                                                                                                                  

   \<10                           1509 (16.6)                               7498 (16.5)               21 411 (15.3)    75 848 (13.7)    181 808 (13.4)     16 089 (18.0)

   10-12                          4218 (46.3)                               21 524 (47.4)             65 466 (46.7)    247 739 (44.9)   591 395 (43.7)     38 777 (43.3)

   \>12                           3380 (37.1)                               16 431 (36.1)             53 385 (38.1)    228 267 (41.4)   580 085 (42.9)     34 647 (38.7)

  Employment                      7530 (82.7)                               38 293 (84.3)             120 085 (85.6)   474 869 (86.0)   1 173 768 (86.7)   75 520 (84.4)

  Income (group)                                                                                                                                           

   1st (highest)                  2500 (27.4)                               10 395 (22.9)             31 264 (22.3)    131 193 (23.8)   348 942 (25.8)     24 446 (27.3)

   2nd                            2225 (24.4)                               10 730 (23.6)             33 581 (23.9)    132 327 (24.0)   342 045 (25.3)     25 358 (28.3)

   3rd                            1912 (21.0)                               11 606 (25.5)             35 905 (25.6)    138 566 (25.1)   339 010 (25.0)     22 456 (25.1)

   4th (lowest)                   2470 (27.1)                               12 722 (28.0)             39 512 (28.2)    149 768 (27.1)   323 291 (23.9)     17 253 (19.3)

  Birth country or region                                                                                                                                  

   Sweden                         6958 (76.4)                               37 443 (82.4)             116 310 (82.9)   449 542 (81.5)   1 114 652 (82.4)   72 312 (80.8)

   Other Europe, US, and Canada   964 (10.6)                                3976 (8.8)                12 130 (8.7)     48 858 (8.9)     128 986 (9.5)      10 410 (11.6)

   Asia and Oceania               741 (8.1)                                 2673 (5.9)                8359 (6.0)       38 262 (6.9)     73 897 (5.5)       3702 (4.1)

   Africa                         327 (3.6)                                 902 (2.0)                 1933 (1.4)       8164 (1.5)       21 728 (1.6)       2210 (2.5)

   Latin America                  108 (1.2)                                 399 (0.9)                 1391 (1.0)       6486 (1.2)       12 656 (0.9)       759 (0.9)

   Other and unknown              9 (0.1)                                   60 (0.1)                  139 (1.0)        542 (0.1)        1369 (0.1)         120 (0.1)

  Body mass index                                                                                                                                          

   \<18.5                         223 (2.4)                                 1294 (2.9)                4215 (3.0)       16 243 (2.9)     29 739 (2.2)       1048 (1.2)

   18.5-24.9                      6927 (76.1)                               36 701 (80.7)             114 059 (81.3)   450 513 (81.6)   1 110 089 (82.0)   72 124 (80.6)

   25.0-26.9                      826 (9.1)                                 2994 (6.6)                8986 (6.4)       36 556 (6.6)     93 683 (6.9)       6349 (7.1)

   27.0-29.9                      524 (5.7)                                 2182 (4.8)                6689 (4.8)       25 993 (4.7)     64 608 (4.8)       4864 (5.4)

   ≥30.0                          607 (6.7)                                 2282 (5.0)                6313 (4.5)       22 549 (4.1)     55 169 (4.1)       5128 (5.7)

  Smoking (cigarettes/day)                                                                                                                                 

   0                              6603 (72.5)                               31 253 (68.8)             99 901 (71.2)    410 401 (74.4)   992 980 (73.4)     57 915 (64.7)

   1-9                            2061 (22.6)                               12 038 (26.5)             34 535 (24.6)    121 547 (22.0)   321 942 (23.8)     29 569 (33.0)

   ≥10                            443 (4.9)                                 2162 (4.8)                5826 (4.2)       19 906 (3.6)     38 366 (2.8)       2029 (2.3)

  Pre-eclampsia                   1030 (11.3)                               6999 (15.4)               14 165 (10.1)    35 705 (6.5)     61 312 (4.5)       4101 (4.6)

  Other hypertensive disorders    102 (1.1)                                 681 (1.5)                 1758 (1.3)       6234 (1.1)       12 615 (0.9)       738 (0.8)

  Diabetes mellitus               214 (2.4)                                 1390 (3.1)                4323 (3.1)       9995 (1.8)       11 098 (0.8)       477 (0.5)

  Asthma                          324 (3.6)                                 1447 (3.2)                4191 (3.0)       15 344 (2.8)     32 089 (2.4)       1990 (2.2)

  Rheumatoid arthritis            60 (0.7)                                  322 (0.7)                 966 (0.7)        3267 (0.6)       6302 (0.5)         406 (0.5)

  Depression                      619 (6.8)                                 2501 (5.5)                7411 (5.3)       27 163 (4.9)     54 434 (5.0)       3663 (4.1)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Median age at first delivery was 27.0 (mean 27.2, standard deviation 5.2) and 50.4 (50.6, 13.4) at the end of follow-up. In 50.7 million person years of follow-up, 76 535(3.5%) women died (median age at death was 57.6; mean 56.3, standard deviation 12.2). [Table 2](#tbl2){ref-type="table"} reports absolute mortality rates by length of pregnancy and follow-up time.

###### 

Associations between length of pregnancy in women and all cause mortality

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                     Deaths   Rate\*\   Reduced model (hazard ratio, 95% CI)†   Full model‡           Risk difference (95% CI)§   AF (%)\                  PAF (%)\   
  ---------------------------------- -------- --------- --------------------------------------- --------------------- --------------------------- ------------------------ ---------- -----
  **0-44 years after delivery**                                                                                                                                                       

  Preterm (\<37 weeks)               8618     206.5     1.50 (1.47 to 1.54)                     1.41 (1.38 to 1.45)   \<0.001                     63.6 (58.2 to 69.0)      30.8       4.8

   Extremely preterm (22-27 weeks)   378      227.0     1.82 (1.64 to 2.01)                     1.70 (1.54 to 1.89)   \<0.001                     84.1 (54.9 to 113.3)     37.8       0.3

   Very preterm (28-33 weeks)        2315     234.2     1.72 (1.65 to 1.80)                     1.61 (1.54 to 1.68)   \<0.001                     91.3 (79.5 to 103.1)     39.4       1.9

   Late preterm (34-36 weeks)        5925     196.9     1.42 (1.38 to 1.45)                     1.34 (1.30 to 1.37)   \<0.001                     54.0 (47.9 to 60.2)      27.4       3.0

  Early term (37-38 weeks)           17 671   162.4     1.16 (1.13 to 1.18)                     1.11 (1.09 to 1.13)   \<0.001                     19.5 (16.4 to 22.6)      12.0       3.2

  Full term (39-41 weeks)            45 338   142.9     Reference                               Reference             ---                         Reference                ---        ---

  Post-term (≥42 weeks)              4908     158.9     1.05 (1.03 to 1.08)                     1.03 (1.00 to 1.07)   0.02                        16.0 (12.4 to 19.6)      10.1       1.5

  Per additional week (trend)        ---      ---       0.96 (0.95 to 0.96)                     0.96 (0.95 to 0.96)   \<0.001                     ---                      ---        ---

  **\<10 years after delivery**                                                                                                                                                       

  Preterm (\<37 weeks)               849      58.4      1.85 (1.72 to 1.99)                     1.73 (1.61 to 1.87)   \<0.001                     28.3 (23.8 to 32.8)      48.0       8.7

   Extremely preterm (22-27 weeks)   44       71.8      2.18 (1.62 to 2.93)                     2.20 (1.63 to 2.96)   \<0.001                     41.7 (20.4 to 62.9)      58.0       0.7

   Very preterm (28-33 weeks)        269      80.0      2.50 (2.21 to 2.83)                     2.28 (2.01 to 2.58)   \<0.001                     49.9 (40.3 to 59.5)      62.3       4.1

   Late preterm (34-36 weeks)        536      50.2      1.62 (1.48 to 1.77)                     1.52 (1.39 to 1.67)   \<0.001                     20.1 (15.8 to 24.5)      41.3       4.9

  Early term (37-38 weeks)           1532     38.7      1.23 (1.15 to 1.31)                     1.19 (1.12 to 1.27)   \<0.001                     8.6 (6.2 to 11.0)        21.9       5.2

  Full term (39-41 weeks)            3832     30.1      Reference                               Reference             ---                         Reference                ---        ---

  Post-term (≥42 weeks)              437      32.1      1.06 (0.98 to 1.16)                     0.99 (0.90 to 1.10)   0.92                        2.0 (−0.8 to 4.7)        6.0        0.8

  Per additional week (trend)        ---      ---       0.93 (0.92 to 0.94)                     0.93 (0.92 to 0.94)   \<0.001                     ---                      ---        ---

  **10-19 years after delivery**                                                                                                                                                      

  Preterm (\<37 weeks)               1536     126.3     1.52 (1.44 to 1.61)                     1.45 (1.37 to 1.53)   \<0.001                     48.0 (40.1 to 55.7)      38.0       5.8

   Extremely preterm (22-27 weeks)   62       123.7     1.53 (1.19 to 1.96)                     1.49 (1.16 to 1.91)   0.002                       45.4 (15.5 to 75.3)      36.7       0.3

   Very preterm (28-33 weeks)        416      147.9     1.74 (1.57 to 1.92)                     1.63 (1.47 to 1.80)   \<0.001                     69.6 (52.3 to 86.9)      47.1       2.3

   Late preterm (34-36 weeks)        1058     119.7     1.45 (1.36 to 1.55)                     1.39 (1.30 to 1.48)   \<0.001                     41.4 (32.6 to 50.1)      34.6       3.7

  Early term (37-38 weeks)           3015     96.2      1.17 (1.12 to 1.23)                     1.10 (1.06 to 1.15)   \<0.001                     17.9 (13.5 to 22.2)      18.6       4.2

  Full term (39-41 weeks)            7026     78.3      Reference                               Reference             ---                         Reference                ---        ---

  Post-term (≥42 weeks)              680      81.0      1.05 (0.98 to 1.11)                     1.04 (0.96 to 1.13)   0.32                        2.7 (−2.2 to 7.5)        3.3        0.4

  Per additional week (trend)        ---      ---       0.96 (0.95 to 0.97)                     0.96 (0.95 to 0.96)   \<0.001                     ---                      ---        ---

  **20-44 years after delivery**                                                                                                                                                      

  Preterm (\<37 weeks)               6233     476.3     1.45 (1.41 to 1.49)                     1.37 (1.33 to 1.41)   \<0.001                     143.4 (128.7 to 158.3)   30.1       3.3

   Extremely preterm (22-27 weeks)   272      600.6     1.84 (1.63 to 2.07)                     1.68 (1.49 to 1.89)   \<0.001                     267.7 (176.3 to 359.2)   44.6       0.3

   Very preterm (28-33 weeks)        1630     522.3     1.62 (1.54 to 1.70)                     1.52 (1.44 to 1.60)   \<0.001                     189.4 (157.6 to 221.2)   36.3       1.3

   Late preterm (34-36 weeks)        4331     457.0     1.37 (1.33 to 1.42)                     1.30 (1.26 to 1.35)   \<0.001                     124.1 (107.4 to 140.9)   27.2       2.0

  Early term (37-38 weeks)           13 124   387.1     1.14 (1.12 to 1.17)                     1.10 (1.08 to 1.13)   \<0.001                     54.2 (45.8 to 62.8)      14.0       2.9

  Full term (39-41 weeks)            34 480   332.9     Reference                               Reference             ---                         Reference                ---        ---

  Post-term (≥42 weeks)              3791     344.0     1.05 (1.02 to 1.08)                     1.04 (1.00 to 1.07)   0.03                        11.1 (2.2 to 20.0)       3.2        0.5

  Per additional week (trend)        ---      ---       0.96 (0.96 to 0.96)                     0.96 (0.96 to 0.96)   \<0.001                     ---                      ---        ---
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AF=attributable fraction in the respective pregnancy length group. PAF=population attributable fraction.

Mortality rate per 100 000 person years.

Adjusted for maternal age as the Cox model time scale.

Further adjusted for year of delivery, parity, education, employment, income, region of origin, body mass index, smoking, pre-eclampsia, other hypertensive disorders, diabetes, asthma, rheumatoid arthritis, and depression.

Mortality rate difference per 100 000 person years.

Length of pregnancy and all cause mortality
-------------------------------------------

Across the total follow-up time (0-44 years after first delivery), each additional week of pregnancy was associated with a 4% lower risk of death (full model: adjusted hazard ratio 0.96, 95% confidence interval 0.95 to 0.96; P\<0.001) ([table 2](#tbl2){ref-type="table"}). Compared with full term delivery, the adjusted hazard ratios for mortality associated with preterm, extremely preterm, or early term delivery were 1.41 (95% confidence interval 1.38 to 1.45), 1.70 (1.54 to 1.89), and 1.11 (1.09 to 1.13), respectively. These fully adjusted hazard ratios were only modestly lower than those adjusted only for age ([table 2](#tbl2){ref-type="table"}).

During the first 10 years after delivery, the adjusted hazard ratio for mortality associated with preterm delivery was 1.73 (95% confidence interval 1.61 to 1.87), and when further stratified was 2.20 (1.63 to 2.96) for extremely preterm delivery, 2.28 (2.01 to 2.58) for very preterm delivery, 1.52 (1.39 to 1.67) for late preterm delivery, and 1.19 (1.12 to 1.27) for early term delivery, compared with full term delivery ([table 2](#tbl2){ref-type="table"}). After longer follow-up times (10-19 and 20-44 years after delivery), the association between preterm delivery and mortality declined but remained significantly raised (eg, full model: adjusted hazard ratio 10-19 years after delivery was 1.45, 95% confidence interval 1.37 to 1.53, P\<0.001; adjusted hazard ratio 20-44 years after delivery was 1.37, 1.33 to 1.41, P\<0.001). Early term delivery was associated with a slightly increased risk of mortality, even 20-44 years later, compared with full term delivery (adjusted hazard ratio 1.10, 1.08 to 1.13, P\<0.001).

Whereas hazard ratios were highest in the first 10 years after delivery and then declined, absolute mortality differences associated with preterm delivery increased with longer follow-up times ([fig 1](#f1){ref-type="fig"}). Preterm delivery accounted for 28.3 (95% confidence interval 23.8 to 32.8) excess deaths per 100 000 person years at less than 10 years after delivery, 48.0 (40.1 to 55.7) excess deaths at 10-19 years after delivery, and 143.4 (128.7 to 158.3) excess deaths at 20-44 years after delivery, compared with full term delivery ([table 2](#tbl2){ref-type="table"}, risk differences). At less than 10, 10-19, and 20-44 years of follow-up, respectively, an estimated 48.0%, 38.0%, and 30.1% of deaths in women who delivered preterm, and 8.7%, 5.8%, and 3.3% of all deaths in the population, were related to preterm delivery ([table 2](#tbl2){ref-type="table"}, attributable fraction and population attributable fraction). An estimated 2654 excess deaths in this population were associated with preterm delivery (one excess death per 73 women who delivered preterm). Kaplan-Meier survival curves by length of pregnancy are shown in supplementary figure 1.

![Hazard ratios and absolute risk differences for all cause mortality in women by length of pregnancy compared with full term, Sweden, 1973-2016](cruc054946.f1){#f1}

In sensitivity analyses that were restricted to women with complete data or that coded missing data with a missing data indicator, all results were similar to the main results, and the overall conclusions were unchanged (eg, fully adjusted hazard ratios for mortality after 0-44 years of follow-up for preterm compared with full term were 1.34 (95% confidence interval 1.28 to 1.40), P\<0.001 and 1.40 (1.37 to 1.43), P\<0.001, respectively). In the complete case analysis, adjustment for maternal body mass index and smoking had only a modest effect on risk estimates (that is, they were not major confounders). Also, the corresponding adjusted hazard ratio when considering each woman's first delivery, instead of her shortest pregnancy adjusted for parity, was 1.42 (95% confidence interval 1.38 to 1.46, P\<0.001).

Co-sibling analyses
-------------------

Co-sibling analyses to control for unmeasured shared familial factors showed little change in risk estimates ([table 3](#tbl3){ref-type="table"}). For example, comparing preterm with full term delivery, the adjusted hazard ratios for mortality at less than 10 years after delivery were 1.73 (95% confidence interval 1.61 to 1.87) in the primary analysis versus 1.68 (1.20 to 2.35) in the co-sibling analysis; at 10-19 years after delivery, 1.45 (1.37 to 1.53) versus 1.46 (1.19 to 1.80); and at 20-44 years after delivery, 1.37 (1.33 to 1.41) versus 1.37 (1.27 to 1.49). These findings suggested that the associations seen in the primary analyses were not attributable to shared genetic or early life environmental factors in families.

###### 

Co-sibling analyses of length of pregnancy in women and all cause mortality

                                   Deaths   Hazard ratio (95% CI)\*   P value
  -------------------------------- -------- ------------------------- ---------
  **0-44 years after delivery**                                       
  Preterm (\<37 weeks)             5018     1.39 (1.30 to 1.48)       \<0.001
  Early term (37-38 weeks)         10 077   1.10 (1.05 to 1.16)       \<0.001
  Full term (39-41 weeks)          19 738   Reference                 ---
  Per additional week (trend)      ---      0.95 (0.94 to 0.96)       \<0.001
  **\<10 years after delivery**                                       
  Preterm (\<37 weeks)             940      1.68 (1.20 to 2.35)       0.003
  Early term (37-38 weeks)         1694     1.20 (0.93 to 1.56)       0.17
  Full-term (39-41 weeks)          3047     Reference                 ---
  Per additional week (trend)      ---      0.92 (0.88 to 0.96)       \<0.001
  **10-19 years after delivery**                                      
  Preterm (\<37 weeks)             1402     1.46 (1.19 to 1.80)       \<0.001
  Early term (37-38 weeks)         2812     1.12 (0.97 to 1.30)       0.11
  Full term (39-41 weeks)          4926     Reference                 ---
  Per additional week (trend)      ---      0.95 (0.93 to 0.98)       0.001
  **20-44 years after delivery**                                      
  Preterm (\<37 weeks)             2676     1.37 (1.27 to 1.49)       \<0.001
  Early term (37-38 weeks)         5571     1.08 (1.02 to 1.14)       0.01
  Full term (39-41 weeks)          11 765   Reference                 ---
  Per additional week (trend)      ---      0.96 (0.95 to 0.97)       \<0.001

Adjusted for shared familial (genetic and environmental) factors, and also for maternal age, year of delivery, parity, education, employment, income, body mass index, smoking, pre-eclampsia, other hypertensive disorders, diabetes, asthma, rheumatoid arthritis, and depression.

Length of pregnancy and cause specific mortality
------------------------------------------------

Associations between length of pregnancy and cause specific mortality are reported in [table 4](#tbl4){ref-type="table"}. In the whole cohort, 10 753 (14.0%) deaths were from cardiovascular disease, 37 371 (48.8%) from cancer (including 8447 (11.0%) from breast cancer), 2704 (3.5%) from respiratory disorders, 900 (1.2%) from diabetes, and 24 807 (32.4%) from other causes. Comparing preterm with full term delivery, the adjusted hazard ratio for cardiovascular mortality across the whole follow-up time (0-44 years) was 1.79 (95% confidence interval 1.69 to 1.90, P\<0.001), for any cancer mortality was 1.18 (1.14 to 1.23, P\<0.001), for breast cancer mortality was 1.11 (1.03 to 1.20, P=0.009), for respiratory mortality was 2.15 (1.92 to 2.40, P\<0.001), for diabetes mortality was 3.20 (2.69 to 3.82, P\<0.001), and for all other causes combined was 1.53 (1.47 to 1.59, P\<0.001). Each of these outcomes had a gradient of higher risks by shorter length of pregnancy ([table 4](#tbl4){ref-type="table"}).

###### 

Associations between length of pregnancy in women and cause specific mortality with up to 44 years of follow-up

                                     Deaths   Hazard ratio (95% CI)\*   P value
  ---------------------------------- -------- ------------------------- ---------
  **Cardiovascular**                                                    
  Preterm (\<37 weeks)               1475     1.79 (1.69 to 1.90)       \<0.001
   Extremely preterm (22-27 weeks)   62       2.09 (1.62 to 2.68)       \<0.001
   Very preterm (28-33 weeks)        446      2.30 (2.09 to 2.54)       \<0.001
   Late preterm (34-36 weeks)        967      1.62 (1.51 to 1.73)       \<0.001
  Early term (37-38 weeks)           2592     1.26 (1.21 to 1.32)       \<0.001
  Full term (39-41 weeks)            5941     Reference                 ---
  Post-term (≥42 weeks)              745      1.11 (1.02 to 1.19)       0.01
  Per additional week (trend)        ---      0.91 (0.90 to 0.92)       \<0.001
  **Cancer**                                                            
  Preterm (\<37 weeks)               3519     1.18 (1.14 to 1.23)       \<0.001
   Extremely preterm (22-27 weeks)   142      1.34 (1.13 to 1.58)       0.001
   Very preterm (28-33 weeks)        903      1.29 (1.21 to 1.38)       \<0.001
   Late preterm (34-36 weeks)        2474     1.14 (1.10 to 1.19)       \<0.001
  Early term (37-38 weeks)           8321     1.04 (1.01 to 1.06)       0.007
  Full term (39-41 weeks)            23 169   Reference                 ---
  Post-term (≥42 weeks)              2362     1.00 (0.96 to 1.05)       0.83
  Per additional week (trend)        ---      0.97 (0.97 to 0.98)       \<0.001
  **Breast cancer**                                                     
  Preterm (\<37 weeks)               752      1.11 (1.03 to 1.20)       0.009
   Extremely preterm (22-27 weeks)   35       1.45 (1.04 to 2.02)       0.03
   Very preterm (28-33 weeks)        195      1.23 (1.06 to 1.42)       0.005
   Late preterm (34-36 weeks)        522      1.05 (0.96 to 1.15)       0.26
  Early term (37-38 weeks)           1938     1.03 (0.98 to 1.09)       0.26
  Full term (39-41 weeks)            5234     Reference                 ---
  Post-term (≥42 weeks)              523      1.06 (0.97 to 1.16)       0.19
  Per additional week (trend)        ---      0.99 (0.98 to 1.00)       0.07
  **Respiratory**                                                       
  Preterm (\<37 weeks)               416      2.15 (1.92 to 2.40)       \<0.001
   Extremely preterm (22-27 weeks)   23       3.24 (2.14 to 4.90)       \<0.001
   Very preterm (28-33 weeks)        96       2.11 (1.71 to 2.60)       \<0.001
   Late preterm (34-36 weeks)        297      2.11 (1.86 to 2.39)       \<0.001
  Early term (37-38 weeks)           630      1.31 (1.19 to 1.44)       \<0.001
  Full term (39-41 weeks)            1478     Reference                 ---
  Post-term (≥42 weeks)              180      0.99 (0.84 to 1.15)       0.86
  Per additional week (trend)        ---      0.90 (0.89 to 0.91)       \<0.001
  **Diabetes**                                                          
  Preterm (\<37 weeks)               237      3.20 (2.69 to 3.82)       \<0.001
   Extremely preterm (22-27 weeks)   9        4.37 (2.24 to 8.53)       \<0.001
   Very preterm (28-33 weeks)        60       3.84 (2.90 to 5.07)       \<0.001
   Late preterm (34-36 weeks)        168      2.98 (2.45 to 3.61)       \<0.001
  Early term (37-38 weeks)           263      1.66 (1.41 to 1.96)       \<0.001
  Full term (39-41 weeks)            359      Reference                 ---
  Post-term (≥42 weeks)              41       0.99 (0.72 to 1.37)       0.96
  Per additional week (trend)        ---      0.84 (0.82 to 0.86)       \<0.001
  **Other causes**                                                      
  Preterm (\<37 weeks)               2971     1.53 (1.47 to 1.59)       \<0.001
   Extremely preterm (22-27 weeks)   142      1.94 (1.64 to 2.29)       \<0.001
   Very preterm (28-33 weeks)        810      1.77 (1.65 to 1.90)       \<0.001
   Late preterm (34-36 weeks)        2019     1.43 (1.36 to 1.50)       \<0.001
  Early term (37-38 weeks)           5865     1.16 (1.13 to 1.20)       \<0.001
  Full term (39-41 weeks)            14 391   Reference                 ---
  Post-term (≥42 weeks)              1580     1.04 (0.99 to 1.10)       0.13
  Per additional week (trend)        ---      0.94 (0.94 to 0.95)       \<0.001

Adjusted for maternal age, year of delivery, parity, education, employment, income, region of origin, body mass index, smoking, pre-eclampsia, other hypertensive disorders, diabetes, asthma, rheumatoid arthritis, and depression.

Secondary analyses
------------------

[Table 5](#tbl5){ref-type="table"} reports the associations between the number of preterm deliveries and mortality. Women with more than one preterm delivery had further increases in mortality risk. In women with at least two singleton deliveries, the adjusted hazard ratios for mortality for each additional preterm delivery were 1.13 (95% confidence interval 1.04 to 1.24) at less than 10 years, 1.25 (1.19 to 1.31) at 10-19 years, and 1.24 (1.21 to 1.27) at 20-44 years after first delivery.

###### 

Associations between number of preterm deliveries and all cause mortality in women with two or more singleton deliveries

                                         Deaths   Rate\*   Hazard ratio (95% CI)†   P value
  -------------------------------------- -------- -------- ------------------------ ---------
  **0-44 years after first delivery**                                               
  0 preterm                              29 845   95.7     Reference                ---
  1 preterm                              4000     130.0    1.27 (1.23 to 1.31)      \<0.001
  ≥2 preterm                             1074     161.5    1.61 (1.51 to 1.71)      \<0.001
  Per additional preterm delivery        ---      ---      1.24 (1.21 to 1.27)      \<0.001
  **\<10 years after first delivery**                                               
  0 preterm                              1883     15.3     Reference                ---
  1 preterm                              286      24.0     1.38 (1.22 to 1.57)      \<0.001
  ≥2 preterm                             43       16.8     0.92 (0.68 to 1.24)      0.57
  Per additional preterm delivery        ---      ---      1.13 (1.04 to 1.24)      0.005
  **10-19 years after first delivery**                                              
  0 preterm                              5227     56.6     Reference                ---
  1 preterm                              746      81.1     1.31 (1.21 to 1.41)      \<0.001
  ≥2 preterm                             207      103.4    1.62 (1.41 to 1.86)      \<0.001
  Per additional preterm delivery        ---      ---      1.25 (1.19 to 1.31)      \<0.001
  **20-44 years after first delivery**                                              
  0 preterm                              22 735   235.8    Reference                ---
  1 preterm                              2968     306.9    1.25 (1.20 to 1.30)      \<0.001
  ≥2 preterm                             824      395.1    1.65 (1.54 to 1.77)      \<0.001
  Per additional preterm delivery        ---      ---      1.24 (1.21 to 1.27)      \<0.001

Mortality rate per 100 000 person years.

Adjusted for maternal age, year of delivery, parity, education, employment, income, region of origin, body mass index, smoking, pre-eclampsia, other hypertensive disorders, diabetes, asthma, rheumatoid arthritis, and depression.

Spontaneous and medically indicated preterm delivery were associated with significantly increased mortality compared with full term delivery (adjusted hazard ratios 1.21 (95% confidence interval 1.08 to 1.35, P=0.001) and 1.70 (1.52 to 1.90, P\<0.001), respectively), but medically indicated preterm delivery (eg, for pre-eclampsia or other complications) was the stronger risk factor (P\<0.001 for difference in hazard ratios).

Interactions between length of pregnancy and pre-eclampsia are reported in supplementary table 1. Preterm delivery was associated with increased mortality risks in the long term when pre-eclampsia was present (adjusted hazard ratio 1.59, 95% confidence interval 1.53 to 1.65, P\<0.001) or not present (1.51, 1.45 to 1.56, P\<0.001) (supplementary table 1). No significant interactions were found between preterm delivery and pre-eclampsia on the additive or multiplicative scale.

Preterm delivery and having an infant who was small for gestational age were independently associated with increased mortality (eg, adjusted hazard ratios: preterm *v* full term, 1.40 (95% confidence interval 1.36 to 1.44, P\<0.001); small for gestational age *v* appropriate for gestational age, 1.33 (1.30 to 1.36, P\<0.001)), but preterm delivery was the stronger risk factor (P=0.004 for difference in hazard ratios). Women who delivered preterm had increased mortality regardless of whether their infant was small for gestational age (adjusted hazard ratio 1.29 (1.21 to 1.38), P\<0.001) or appropriate for gestational age (1.42 (1.38 to 1.46), P\<0.001; supplementary table 2). A negative multiplicative (but not additive) interaction was found between preterm delivery and small for gestational age (that is, their combined effect on long term mortality was less than the product of their separate effects, P=0.008). The absence of an additive interaction suggests that preterm delivery was associated with a similar number of deaths in women who had infants who were appropriate for gestational age versus small for gestational age. Stratified subanalyses showed that associations between length of pregnancy or number of preterm deliveries and mortality did not vary significantly by maternal age (\<35 *v* ≥35) or calendar year (\<1980 *v* ≥1980) at first delivery (supplementary table 3).

Discussion
==========

In this large national cohort, length of pregnancy in women was inversely associated with their long term mortality risk, after adjusting for many other risk factors. Women who delivered preterm or extremely preterm had 1.7-fold and 2.2-fold mortality risks, respectively, during the next 10 years compared with those who delivered full term. These risks subsequently declined but remained significantly raised even 20-44 years after delivery (more than 1.3-fold and 1.6-fold, respectively). Even early term delivery (37-38 weeks) was associated with modestly increased mortality risks that persisted 20-44 years later. Co-sibling analyses suggested that these findings were not explained by shared genetic or early life environmental factors in families. The absolute mortality risks associated with preterm delivery were overall low but increased with longer follow-up times. Several major causes of death were identified, including cardiovascular and respiratory disorders, diabetes, and cancer.

Strengths and limitations of the study
--------------------------------------

A key strength of the study was the large national cohort design with up to 44 years of follow-up. The availability of highly complete birth, death, and covariate data from national registries helped minimise potential selection and ascertainment biases. The large sample size enabled high statistical power needed to examine narrowly defined pregnancy durations. The results were controlled for many other maternal factors, and unmeasured shared familial factors by co-sibling analyses, which have not been conducted in previous studies.

Our study had some limitations. Information on spontaneous or medically indicated preterm delivery was available from 1990, which allowed exploratory analyses only in a large subcohort. More complete assessment of the underlying causes of preterm delivery would be useful in future studies to further improve risk stratification. Despite controlling for many maternal factors and shared familial exposures, residual confounding by maternal smoking, body mass index, or other factors is still possible. The study was limited to Sweden and the results might not be applicable to other countries. The study should be repeated in other diverse populations to explore for potential heterogeneity of findings in racial and ethnic subgroups. Longer follow-up to older ages will be needed in this or other large cohorts when such data become available.

Comparison with other studies
-----------------------------

Three smaller studies that explored mortality in women who delivered preterm had conflicting results. A Finnish study of 3706 women who gave birth in 1954-63 reported that preterm delivery was associated with increased cardiovascular mortality (adjusted hazard ratio 2.06, 95% confidence interval 1.22 to 3.47) but not all cause mortality (0.96, 0.67 to 1.38) after follow-up to 1997.[@ref8] Preterm delivery was associated with modestly increased all cause mortality, however, in a Scottish study of 129 920 women who gave birth in 1981-85 with follow-up to 1999 (adjusted hazard ratio 1.5, 95% confidence interval 1.2 to 1.8),[@ref9] and in a Swedish study of 573 437 women who gave birth in 1973-80 with follow-up to 1997 (1.23, 1.14 to 1.34).[@ref10] These studies examined all preterm deliveries combined (\<37 weeks) and had insufficient numbers to examine narrower pregnancy durations.

Our findings are generally consistent with previous studies that explored the birth weight of infants (which is influenced by length of pregnancy and fetal growth rate) in relation to future health risks in the mother.[@ref5] [@ref6] [@ref7] [@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] [@ref14] The largest was an Israeli study of 982 091 women who gave birth in 1995-2010, which reported that those whose infants weighed less than 1500 g had a twofold mortality over 17 years of follow-up compared with birth weights of 3000-3500 g (adjusted hazard ratio 2.13, 95% confidence interval 1.68 to 2.71).[@ref5] This finding was consistent with those from smaller cohorts of women who gave birth in 1958 in the UK[@ref7] and in 1974-76 in Israel.[@ref6] Other studies reported increased cardiovascular[@ref7] [@ref8] [@ref9] [@ref10] [@ref11] [@ref12] [@ref13] and diabetes related[@ref14] mortality in women who delivered an infant with a low birth weight.

Birth weight in infants is determined by both length of pregnancy and fetal growth rate, which have different underlying processes. Our study extends previous evidence as we examined length of pregnancy more specifically in relation to long term mortality in a large population based cohort with several decades of follow-up. Our findings suggested that preterm and early term delivery were independent risk factors for increased mortality up to 40 years later. Mortality was increased after spontaneous or (even higher) medically indicated preterm delivery, and with or without pre-eclampsia or fetal growth restriction. These findings suggest that all women who deliver preterm, and not only subgroups with other major complications, have raised mortality risks.

We found several major causes of death associated with preterm delivery, including cardiovascular and respiratory disorders, diabetes, cancer, and other causes. These findings are similar to previously reported cause specific mortality in the offspring of preterm birth.[@ref20] [@ref22] [@ref23] Common genetic factors have been proposed that might contribute to preterm delivery and future health outcomes.[@ref24] Co-sibling analyses, however, suggested that our findings were largely independent of shared genetic or early life environmental factors within families. Instead, individual specific processes involved with preterm delivery might contribute directly to subsequent development of chronic disorders and early mortality in women. The mechanisms are not established but could involve common inflammatory pathways. Increased production of proinflammatory cytokines, specifically interleukin 1, interleukin 6, and tumour necrosis factor, have been associated with uterine activation and the timing and start of preterm delivery.[@ref25] [@ref26] [@ref27] Proinflammatory pathways also play a key role in the pathogenesis of atherosclerosis and cardiovascular disease,[@ref28] [@ref29] [@ref30] chronic pulmonary disease,[@ref31] and specific cancers.[@ref32] Preclinical diabetes and other cardiometabolic disorders might also contribute to preterm delivery and subsequent mortality risks. Other mechanisms are also possible, including a potential role of vitamin D deficiency, which has been associated with preterm delivery[@ref33] [@ref34] and to some extent with cardiovascular, neoplastic, and metabolic disorders, although a direct cause and effect has not been established.[@ref35] [@ref36] Further experimental and clinical studies are needed to identify the relevant mechanisms, which might disclose new targets for prevention.

Implications
------------

Premature delivery should now be recognised as a risk factor for early mortality in women. Medical records and history taking should routinely include reproductive history that covers preterm delivery and other complications of pregnancy. Women with a history of preterm delivery need long term follow-up for recommended screenings to facilitate detection and treatment of chronic disorders associated with early mortality, including cardiovascular, neoplastic, and metabolic disease. Better access to high quality preconception and prenatal care should also be a public health priority to help reduce preterm delivery.[@ref37]

Conclusions
-----------

This large national cohort study suggested that preterm and early term delivery were independent risk factors for premature mortality from several major causes, and that the associated risks persist for up to 40 years later. Women who deliver prematurely need long term clinical follow-up for detection and treatment of chronic disorders associated with early mortality.

### What is already known on this topic

1.  Nearly 11% of all deliveries worldwide occur preterm (gestational age \<37 weeks)

2.  Women who deliver preterm have been reported to have increased future risks of developing heart disease and other cardiometabolic disorders, but little is known about their long term mortality risks

### What this study adds

1.  In a large national cohort, preterm and early term delivery were independent risk factors for premature mortality in women up to 40 years later

2.  These findings were not explained by shared genetic or early life environmental factors in families

3.  Women who deliver prematurely need long term clinical follow-up for detection and treatment of chronic disorders associated with early mortality
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